These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1310 related items for PubMed ID: 22955358

  • 1. Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome.
    Barbara G, Zecchi L, Barbaro R, Cremon C, Bellacosa L, Marcellini M, De Giorgio R, Corinaldesi R, Stanghellini V.
    J Clin Gastroenterol; 2012 Oct; 46 Suppl():S52-5. PubMed ID: 22955358
    [Abstract] [Full Text] [Related]

  • 2. Probiotics and irritable bowel syndrome: rationale and clinical evidence for their use.
    Barbara G, Stanghellini V, Cremon C, De Giorgio R, Gargano L, Cogliandro R, Pallotti F, Corinaldesi R.
    J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 2():S214-7. PubMed ID: 18685517
    [Abstract] [Full Text] [Related]

  • 3. Treating irritable bowel syndrome with probiotics: the evidence.
    Parkes GC, Sanderson JD, Whelan K.
    Proc Nutr Soc; 2010 May; 69(2):187-94. PubMed ID: 20236566
    [Abstract] [Full Text] [Related]

  • 4. Aminosalicylates and other anti-inflammatory compounds for irritable bowel syndrome.
    Barbara G, Stanghellini V, Cremon C, De Giorgio R, Fronzoni L, Serra M, Corinaldesi R.
    Dig Dis; 2009 May; 27 Suppl 1():115-21. PubMed ID: 20203507
    [Abstract] [Full Text] [Related]

  • 5. Mucosal barrier defects in irritable bowel syndrome. Who left the door open?
    Barbara G.
    Am J Gastroenterol; 2006 Jun; 101(6):1295-8. PubMed ID: 16771952
    [Abstract] [Full Text] [Related]

  • 6. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
    Ki Cha B, Mun Jung S, Hwan Choi C, Song ID, Woong Lee H, Joon Kim H, Hyuk J, Kyung Chang S, Kim K, Chung WS, Seo JG.
    J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240
    [Abstract] [Full Text] [Related]

  • 7. Review article: probiotics and prebiotics in irritable bowel syndrome.
    Spiller R.
    Aliment Pharmacol Ther; 2008 Aug 15; 28(4):385-96. PubMed ID: 18532993
    [Abstract] [Full Text] [Related]

  • 8. The rationale and clinical effectiveness of probiotics in irritable bowel syndrome.
    Ringel Y, Ringel-Kulka T.
    J Clin Gastroenterol; 2011 Nov 15; 45 Suppl():S145-8. PubMed ID: 21992954
    [Abstract] [Full Text] [Related]

  • 9. Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhoea-predominant irritable bowel syndrome.
    Zeng J, Li YQ, Zuo XL, Zhen YB, Yang J, Liu CH.
    Aliment Pharmacol Ther; 2008 Oct 15; 28(8):994-1002. PubMed ID: 18671775
    [Abstract] [Full Text] [Related]

  • 10. Probiotics and irritable bowel syndrome: rationale, mechanisms, and efficacy.
    Camilleri M.
    J Clin Gastroenterol; 2008 Sep 15; 42 Suppl 3 Pt 1():S123-5. PubMed ID: 18806702
    [Abstract] [Full Text] [Related]

  • 11. Stress and the gut: pathophysiology, clinical consequences, diagnostic approach and treatment options.
    Konturek PC, Brzozowski T, Konturek SJ.
    J Physiol Pharmacol; 2011 Dec 15; 62(6):591-9. PubMed ID: 22314561
    [Abstract] [Full Text] [Related]

  • 12. Irritable bowel syndrome: methods, mechanisms, and pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome.
    Camilleri M, Lasch K, Zhou W.
    Am J Physiol Gastrointest Liver Physiol; 2012 Oct 15; 303(7):G775-85. PubMed ID: 22837345
    [Abstract] [Full Text] [Related]

  • 13. Gastrointestinal microbiota in irritable bowel syndrome: their role in its pathogenesis and treatment.
    Parkes GC, Brostoff J, Whelan K, Sanderson JD.
    Am J Gastroenterol; 2008 Jun 15; 103(6):1557-67. PubMed ID: 18513268
    [Abstract] [Full Text] [Related]

  • 14. Chronological assessment of mast cell-mediated gut dysfunction and mucosal inflammation in a rat model of chronic psychosocial stress.
    Vicario M, Guilarte M, Alonso C, Yang P, Martínez C, Ramos L, Lobo B, González A, Guilà M, Pigrau M, Saperas E, Azpiroz F, Santos J.
    Brain Behav Immun; 2010 Oct 15; 24(7):1166-75. PubMed ID: 20600818
    [Abstract] [Full Text] [Related]

  • 15. Probiotics and irritable bowel syndrome: a rationale for their use and an assessment of the evidence to date.
    Quigley EM, Flourie B.
    Neurogastroenterol Motil; 2007 Mar 15; 19(3):166-72. PubMed ID: 17300285
    [Abstract] [Full Text] [Related]

  • 16. Review article: Associations between immune activation, intestinal permeability and the irritable bowel syndrome.
    Matricon J, Meleine M, Gelot A, Piche T, Dapoigny M, Muller E, Ardid D.
    Aliment Pharmacol Ther; 2012 Dec 15; 36(11-12):1009-31. PubMed ID: 23066886
    [Abstract] [Full Text] [Related]

  • 17. Mucosal immune cell numbers and visceral sensitivity in patients with irritable bowel syndrome: is there any relationship?
    Braak B, Klooker TK, Wouters MM, Welting O, van der Loos CM, Stanisor OI, van Diest S, van den Wijngaard RM, Boeckxstaens GE.
    Am J Gastroenterol; 2012 May 15; 107(5):715-26. PubMed ID: 22488080
    [Abstract] [Full Text] [Related]

  • 18. A marketed fermented dairy product containing Bifidobacterium lactis CNCM I-2494 suppresses gut hypersensitivity and colonic barrier disruption induced by acute stress in rats.
    Agostini S, Goubern M, Tondereau V, Salvador-Cartier C, Bezirard V, Lévèque M, Keränen H, Theodorou V, Bourdu-Naturel S, Goupil-Feuillerat N, Legrain-Raspaud S, Eutamene H.
    Neurogastroenterol Motil; 2012 Apr 15; 24(4):376-e172. PubMed ID: 22272920
    [Abstract] [Full Text] [Related]

  • 19. Tight junctions and IBS--the link between epithelial permeability, low-grade inflammation, and symptom generation?
    Piche T.
    Neurogastroenterol Motil; 2014 Mar 15; 26(3):296-302. PubMed ID: 24548256
    [Abstract] [Full Text] [Related]

  • 20. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.
    Drouault-Holowacz S, Bieuvelet S, Burckel A, Cazaubiel M, Dray X, Marteau P.
    Gastroenterol Clin Biol; 2008 Feb 15; 32(2):147-52. PubMed ID: 18387426
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 66.